127 related articles for article (PubMed ID: 8633181)
1. The effect of menopause and hormone replacement therapy on bone alkaline phosphatase.
Alexandersen P; Hassager C; Riis BJ
Scand J Clin Lab Invest; 1995 Nov; 55(7):571-6. PubMed ID: 8633181
[TBL] [Abstract][Full Text] [Related]
2. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study.
Khosla S; Atkinson EJ; Melton LJ; Riggs BL
J Clin Endocrinol Metab; 1997 May; 82(5):1522-7. PubMed ID: 9141544
[TBL] [Abstract][Full Text] [Related]
3. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
Peichl P; Griesmacher A; Müller MM; Marteau R; Kumpan W; Bröll H
Gynecol Endocrinol; 2000 Oct; 14(5):374-81. PubMed ID: 11109977
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
Garnero P; Delmas PD
J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
[TBL] [Abstract][Full Text] [Related]
5. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
[TBL] [Abstract][Full Text] [Related]
6. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women.
Chen JT; Hosoda K; Hasumi K; Ogata E; Shiraki M
J Bone Miner Res; 1996 Nov; 11(11):1784-92. PubMed ID: 8915787
[TBL] [Abstract][Full Text] [Related]
7. Osteocalcin and bone-specific alkaline phosphatase in sickle cell haemoglobinopathies.
Azinge EC; Bolarin DM
Niger J Physiol Sci; 2006; 21(1-2):21-5. PubMed ID: 17242729
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
[TBL] [Abstract][Full Text] [Related]
9. High bone turnover is associated with low bone mass in both pre- and postmenopausal women.
Ravn P; Fledelius C; Rosenquist C; Overgaard K; Christiansen C
Bone; 1996 Sep; 19(3):291-8. PubMed ID: 8873970
[TBL] [Abstract][Full Text] [Related]
10. Ovarian hormone status, life-style factors, and markers of bone metabolism in women aged 50 years.
Leino A; Järvisalo J; Impivaara O; Kaitsaari M
Calcif Tissue Int; 1994 Apr; 54(4):262-7. PubMed ID: 8062141
[TBL] [Abstract][Full Text] [Related]
11. Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: a randomized 1-year study.
Störk S; Störk C; Angerer P; Kothny W; Schmitt P; Wehr U; von Schacky C; Rambeck W
Osteoporos Int; 2000; 11(9):790-6. PubMed ID: 11148806
[TBL] [Abstract][Full Text] [Related]
12. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women.
Vural P; Akgul C; Canbaz M
Pharmacol Res; 2006 Oct; 54(4):298-302. PubMed ID: 16879975
[TBL] [Abstract][Full Text] [Related]
13. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
[TBL] [Abstract][Full Text] [Related]
14. Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women.
Weinstein RS; Parfitt AM; Marcus R; Greenwald M; Crans G; Muchmore DB
Osteoporos Int; 2003 Oct; 14(10):814-22. PubMed ID: 14610642
[TBL] [Abstract][Full Text] [Related]
15. Two bone alkaline phosphatase assays compared with osteocalcin as a marker of bone formation in healthy elderly women.
Bouman AA; Scheffer PG; Ooms ME; Lips P; Netelenbos C
Clin Chem; 1995 Feb; 41(2):196-9. PubMed ID: 7874771
[TBL] [Abstract][Full Text] [Related]
16. Effects of continuous percutaneous estradiol administration on skeletal turnover in postmenopausal women: a 1-year prospective controlled study.
Cicinelli E; Cantatore FP; Galantino P; Rubini G; Cerundolo M; Balzano G; D'Aquino TM
Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):109-13. PubMed ID: 8902442
[TBL] [Abstract][Full Text] [Related]
17. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.
Kim JG; Shin CS; Choi YM; Moon SY; Kim SY; Lee JY
Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009
[TBL] [Abstract][Full Text] [Related]
18. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
[TBL] [Abstract][Full Text] [Related]
19. Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women.
Peichl P; Griesmacher A; Pointinger P; Marteau R; Hartl W; Gruber W; Bröll H
Calcif Tissue Int; 1998 May; 62(5):388-94. PubMed ID: 9541515
[TBL] [Abstract][Full Text] [Related]
20. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
